XML 73 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisitions, Divestitures, Research Collaborations and License Agreements - Pro Forma Financial Information (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2015
USD ($)
$ / shares
Business Combinations [Abstract]  
Sales | $ $ 39,584
Net income attributable to Merck & Co., Inc. | $ $ 4,640
Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share) | $ / shares $ 1.65
Earnings per common share assuming dilution attributable to Merck & Co. Inc. common shareholders (in dollars per share) | $ / shares $ 1.63